港股異動 | 去年淨賺230億元 中信證券(6030.HK)漲約4%
格隆匯1月13日丨券商“一哥”中信證券(6030.HK)盤初升近4%,現報21港元,總市值2721億港元。中信證券A股漲1.6%報26.6元。公司2021年實現營收765.70億元,同比增長40.80%,實現歸母淨利潤229.79億元,同比增長54.20%。截至年末,資產總額達到1.28萬億,相比上年末增長了21.28%。公吿顯示,由於國內經濟克服疫情影響、持續向好,資本市場蓬勃發展,中信證券2021年投資銀行、資產管理等各項業務均衡發展、穩步增長。值得注意的是,早在上一週,中信證券搶先發布了業績預增公吿,可謂行業中最早披露業績的券商。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.